Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction

European Journal of Heart Failure
Lars KøberR M Califf

Abstract

To characterize the relationship between known and newly diagnosed atrial fibrillation (AF) and the risk of death and major cardiovascular (CV) events in patients with acute myocardial infarction (MI) complicated by heart failure (HF) and/or left ventricular systolic dysfunction (LVSD). The VALIANT trial enrolled 14,703 individuals with acute MI complicated by HF and/or LVSD. AF was assessed at presentation and at randomization (median 4.9 days after symptom onset). Primary outcomes were risk of death and major CV events 3 years following acute MI. A total of 1812 with current AF (AF between presentation and randomization), 339 patients with prior AF (history of AF without current AF), and 12,509 without AF were enrolled. Patients with AF were older; had more prior HF, angina, and MI, and received beta-blockers and thrombolytics less often than those without AF. Three-year mortality estimates were 20% in those without AF, 37% with current AF, and 38% with prior AF. Compared with patients without AF, the multivariable adjusted HR of death was 1.25 (1.03-1.52; p=0.03) for prior AF and 1.32 (1.20-1.45; p<0.0001) for current AF. HR for major CV events was 1.15 (0.98-1.35; p=0.08) and 1.21 (1.12-1.31; p<0.0001). AF is associated wit...Continue Reading

References

Nov 15, 1996·Journal of the American College of Cardiology·W G StevensonJ H Tillisch
Jul 27, 1999·European Heart Journal·A P Maggioni
Oct 31, 2000·American Heart Journal·M A PfefferR Califf
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Dec 6, 2002·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
Aug 19, 2003·European Journal of Heart Failure·Eric J VelazquezUNKNOWN VALIANT Investigators
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators

❮ Previous
Next ❯

Citations

Jan 8, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Peter BramlageKarl-Heinz Kuck
Feb 4, 2010·Journal of Neurology·Daniel SanákPetr Kanovský
Dec 28, 2011·Current Treatment Options in Cardiovascular Medicine·Christian Jons, Poul Erik Bloch Thomsen
Aug 12, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Alicja BukowskaAndreas Goette
May 4, 2011·Circulation·Patricia JabreVéronique L Roger
Sep 17, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Sanae HamaguchiUNKNOWN Japanese Cardiac Registry of Heart Failure in Cardiology Investigators
Dec 15, 2015·Nature Reviews. Cardiology·Liang-Han LingRoss J Hunter
Dec 8, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi YamauchiUNKNOWN CHART-2 Investigators
Sep 24, 2013·Heart Failure Clinics·Jordi HeijmanDobromir Dobrev
Jul 23, 2013·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Ana Catarina Pinho-GomesMaria Júlia Maciel
Nov 26, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Christian JonsUNKNOWN Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction (CARISMA) Study Group
Jan 17, 2012·Clinical Cardiology·Nihar R Desai, Robert P Giugliano
Apr 21, 2010·European Journal of Heart Failure·Jakob RaunsøUNKNOWN EchoCardiography and Heart Outcome Study Investigators
Sep 30, 2015·Clinical Cardiology·Bijan J BorahAlanna M Chamberlain
May 30, 2015·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·P GalA Elvan
Aug 13, 2015·The New England Journal of Medicine·Sanjit S JollyVladimír Džavík
Jun 22, 2015·American Heart Journal·Abdulla A DamlujiRaul D Mitrani
Apr 4, 2015·Heart Failure Clinics·Philip AagaardAndrea Natale
Jan 15, 2015·Cardiovascular Research·Rohan S Wijesurendra, Barbara Casadei
Aug 19, 2014·Revista Española De Cardiología·Luciano Consuegra-SánchezMarta Vicente-Gilabert
Nov 4, 2015·Archives of Cardiovascular Diseases·Karim StamboulYves Cottin
Apr 10, 2018·Journal of Cardiovascular Electrophysiology·Nav MalhiMarc W Deyell
Mar 26, 2013·Journal of the American Heart Association·David D McManusUNKNOWN Cardiovascular Research Network PRESERVE Study
Jan 8, 2019·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Omer Faruk CirakogluMuhammet Raşit Sayın

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.